{"blog_url":"https://okumi.hatenablog.com/","author_url":"https://blog.hatena.ne.jp/okumi/","author_name":"okumi","description":"Gender Medicine, Vol.7, No.4, 2010 Jill A. Fisher, PhD1; and Lorna M. Ronald, PhD2 1Center for Biomedical Ethics & Society, Vanderbilt University, Nashville, Tennessee; and 2Interdisciplinary Studies Program, John Jay College (City University of New York), New York, New York \u6982\u8981\u3092\u4eee\u8a33\u3057\u307e\u3059\u3002 \u80cc\u666f \u751f\u7269\u5b66\u7684\u6027\u5dee\u3084\u793e\u4f1a\u6587\u5316\u2026","width":"100%","type":"rich","published":"2022-07-07 23:19:26","provider_url":"https://hatena.blog","version":"1.0","provider_name":"Hatena Blog","url":"https://okumi.hatenablog.com/entry/2022/07/07/231926","title":"Sex, Gender, and Pharmaceutical Politics: From Drug Development to Marketing","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fokumi.hatenablog.com%2Fentry%2F2022%2F07%2F07%2F231926\" title=\"Sex, Gender, and Pharmaceutical Politics: From Drug Development to Marketing - \u30ea\u30d7\u30ed\u306a\u65e5\u8a18\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","image_url":null,"blog_title":"\u30ea\u30d7\u30ed\u306a\u65e5\u8a18","height":"190","categories":[]}